← All Sponsors
SPONSOR

Beijing Biotech

Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2, Phase 1
Conditions studied: Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube CarcinomaRecurrent or Refractory Disease After Standard TherapiesGlioblastomaHigh-grade GliomaMalignant GliomaRecurrent GlioblastomaRecurrent High-grade Glioma
NCT07480954 Phase 1, Phase 2
Recruiting

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)

Epithelial Ovarian Cancer
China View Trial →
NCT07480941 Phase 1
Recruiting

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Glioblastoma
China View Trial →